Genoimmune Therapeutics Co., Ltd.

Chengchi Chao

Bo Li

Handong Li

Yong Hou

Shuntao Luo

Xiumei Lin

Ting An

Naibo Yang

Zhen Cheng

Wei Zhang

Geng Liu

Dongli Li

Guanglei Li

Si Qiu

Chongming Jiang

Provided are a tumour antigen polypeptide having the amino acid sequence as shown in SEQ ID NO: 2 or a variant thereof; a nucleic acid encoding same; a nucleic acid construct, an expression vector, and a host cell comprising the encoding nucleic acid; and an antigen presenting cell presenting the tumour antigen polypeptide on the cell surface and an immune effector cell thereof. Also provided is the use of the polypeptide, nucleic acid, antigen presenting cell or immune effector cell in the diagnosis, prevention and treatment of cancers.

Col14A1-derived tumor antigen polypeptide and use thereof

Provided are a tumor antigen polypeptide having the amino acid sequence as shown in SEQ ID NO: 2 or a variant thereof; a nucleic acid encoding the same; a nucleic acid construct, an expression vector, and a host cell containing the encoding nucleic acid; and an antigen presenting cell presenting the tumor antigen polypeptide on the cell surface and an immune effector cell thereof. Also provided is the use of the polypeptide, nucleic acid, antigen presenting cell or immune effector cell in the diagnosis, prevention and treatment of cancers.

CACNA1H-derived tumor antigen polypeptide and use thereof

Growing community of inventors

Guangdong, China

Chengchi Chao